According to a study out of Israel, the South African variant of the coronavirus is thought to be more able to “breaking through” the Pfizer-BioNTech vaccine than other variants.
Researchers from Tel Aviv University and the Clalit healthcare organization sequenced the swabs of 150 Israelis who tested positive for Covid-19, despite have been already vaccinated.
Israel has used the Pfizer vaccine almost exclusively to vaccinate millions.
According to the Times of Israel, the study showed:
the prevalence of the South African strain among vaccinated individuals who were infected despite their inoculation was eight times higher than its prevalence in the unvaccinated infected population. Though the number of such infections among the vaccinated was relatively small, the findings indicated that this variant was far more successful in getting through vaccinated individuals’ defenses than other strains.
Check out some more of our stories: